Lupin acquires UK-based Renascience Pharma for £12.3 million
The portfolio includes branded injectable cephalosporines for infectious diseases
The portfolio includes branded injectable cephalosporines for infectious diseases
Lutio has the potential to offer significant cost savings when available to UK patients.
Subscribe To Our Newsletter & Stay Updated